# Effects of Gender-Affirming Hormone Therapy Among Transgender Women

> **NCT04128488** · — · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 33 (actual)

## Conditions studied

- Transgender Women
- HIV/AIDS
- Cardiovascular Diseases
- Metabolic Disease
- Coagulopathy

## Interventions

- **OTHER:** Abdominal MR Imaging
- **OTHER:** Cardiac MRI/MRS
- **OTHER:** Oral Glucose Tolerance Testing
- **OTHER:** Whole Body, Lumbar Spine, and Hip DEXA Imaging

## Key facts

- **NCT ID:** NCT04128488
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-01
- **Primary completion:** 2024-03-28
- **Final completion:** 2024-03-28
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2025-05-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04128488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04128488, "Effects of Gender-Affirming Hormone Therapy Among Transgender Women". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04128488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*